Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Clinical trial NCT04106167 · TERMINATED

Trial details

NCT number: NCT04106167
Sponsor: Fate Therapeutics
Status: TERMINATED
Study type: OBSERVATIONAL

Advanced Solid Tumor Lymphoma Gastric Cancer Colorectal Cancer Head and Neck Cancer Squamous Cell Carcinoma EGFR Positive Solid Tumor HER2-positive Breast Cancer Hepatocellular Carcinoma Small-cell Lung Cancer Renal Cell Carcinoma Pancreas Cancer

Start date: 2019-06-11
Primary completion: 2023-08-11
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.